The NDEWS team has launched the Rapid Street Reporting (RSR) study, with the first weekend visit occurring November 12-14 in San Francisco. Delayed due to COVID-19, this national venue-intercept study to detect novel psychoactive substances will be conducted in each NDEWS sentinel site, along with five additional hotspots, throughout the next three years. Participant’s zip codes were from: San Francisco, Contra Costa, Alameda, San Mateo, and Santa Clara counties. They were interviewed in public spaces, such as public parks, near bars/restaurants, shopping mall areas, and public transportation stops within San Francisco. The mean age of participants was 33.4 years (SD=12.4, range: 18-72), and participants reported an average of 15.6 years of education (SD=3.2, range: 5-24).
Tags: New Trends Stats Study Trend ReportsCA: Rapid Street Reporting Survey Report: San Francisco Bay Area November 12-14, 2021
-
WV: Announcement of Newly Identified Novel Psychoactive Substance (NPS) in the United States.
Lisa McElhaney / / / Research & Publications
N-Pyrrolidino Etonitazene has been identified in one case in May 2021. The geographical and demographical breakdown is below: Geographical...
-
2021 European Drug Report – Trends and Developments (EMCDDA)
Lisa McElhaney / / / Research & Publications
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) released its 2021 drug report this week. Using data...
-
New Benzodiazepines in Europe – a Review
Lisa McElhaney / / / Research & Publications
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) released an update on benzodiazepines this week. As of February...
-
NFLIS – 2020 Annual Report – Utilizing DEA Synth-Opioids
Lisa McElhaney / / / Research & Publications
The Drug Enforcement Administration’s (DEA’s) Real-Time Communication Synth-Opioids Network (Synth-Opioids) is designed to create opportunities for swift information exchange...
-
New Synthetic Opioid Protonitazene Increasing in Prevalence as “Nitazenes” Gain Traction Across the United States and Canada
Lisa McElhaney / / / Research & Publications
Purpose: The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical...
-
Adverse Effects Linked to Next Generation Opioids Reported in Patients Presenting to Emergency Departments After Suspected Opioid Overdose
Lisa McElhaney / / / Research & Publications
Purpose: The objective of this announcement is to notify public health and safety, clinicians, law enforcement, first responders, medical...
-
Etodesnitazene — New Synthetic Opioid Identified During Forensic Death Investigations in the United States and Canada
Lisa McElhaney / / / Research & Publications
Purpose: The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical...
-
INT: Afghanistan’s ‘tablet K’ – a forensic insight into an emerging synthetic drug market
Lisa McElhaney / / / Research & Publications
Purpose: The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical...
Membership Account
Latest NADDI News
- TX: Doctor Sentenced for $54M Medicare Fraud Scheme October 29, 2024
- China-Based Chemical Manufacturing Companies and Employees Indicted for Alleged Fentanyl Manufacturing and Distribution October 24, 2024
- Massachusetts mother and son sentenced to prison for role in DTO that allegedly distributed 10s of thousands of counterfeit pills containing fentanyl, meth October 13, 2024